Christina Rossi Net Worth & Insider Trades
Christina Rossi - CHIEF OPERATING OFFICER, Blueprint Medicines Corp
What is Christina Rossi's Net Worth?
The current estimated net worth of Blueprint Medicines Corp's CHIEF OPERATING OFFICER, Christina Rossi, is estimated to be about $1.4M . Christina Rossi owns about 55,376 units of Blueprint Medicines Corp common stock. In the last 5 years at Blueprint Medicines Corp, Christina Rossi has sold an estimated value of $510.79K worth.
What is Christina Rossi's Past Insider Trading?
Christina Rossi's largest sale order was 3,059 units , worth over $139.71K on March 8, 2023. In total, Christina Rossi has made about 14 transactions over 5 years of their time at Blueprint Medicines Corp. Christina Rossi usually trades in March, with the busiest year in 2022.
Christina Rossi
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Christina Rossi's' Mailing Address?
- Mailing address is 45 Sidney Street Blueprint Medicines Corporation Cambridge MA 02139 MA
Blueprint Medicines Corp Executive Compensation
Name |
Year
|
Salary
|
Total
|
|---|---|---|---|
| Jeffrey W. Albers | 2020 | $645,000 | $6,344,667 |
| Jeffrey W. Albers | 2019 | $590,000 | $9,362,371 |
| Jeffrey W. Albers | 2018 | $541,144 | $9,740,799 |
| Michael Landsittel | 2020 | $379,575 | $2,014,974 |
| Michael Landsittel | 2019 | $345,000 | $1,958,720 |
| Michael Landsittel | 2018 | $281,678 | $1,740,610 |
| Fouad Namouni, M.D. | 2020 | $186,154 | $6,668,732 |
| Fouad Namouni, M.D. | 2019 | - | - |
| Fouad Namouni, M.D. | 2018 | - | - |
| Kathryn Haviland | 2020 | $460,944 | $2,363,556 |
| Kathryn Haviland | 2019 | $431,830 | $3,090,423 |
| Kathryn Haviland | 2018 | $392,589 | $2,601,762 |
| Tracey L. McCain, Esq. | 2020 | $453,301 | $2,346,428 |
| Tracey L. McCain, Esq. | 2019 | $437,972 | $2,900,568 |
| Tracey L. McCain, Esq. | 2018 | $425,216 | $2,647,962 |
| No matching records found | |||
Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm
What are Blueprint Medicines Corp's Past Insider Trades?
Blueprint Medicines Corp's most recent insider trade came on March 8, 2023 by Christopher Murray who sold 1,875 units worth $85.64K . In the last 8 years, insiders at Blueprint Medicines Corp have sold an estimated value of $175.48M and bought an estimated value of $17.63M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers, Kate Haviland, CHIEF EXECUTIVE OFFICER, and Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER .
Blueprint Medicines Corp Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||